Theoretical and product-level risks FDA's 503A Category 2 listing (active September 29, 2023 to April 23, 2026) flagged Semax for immunogenicity risk for certain routes of administration due to potential for aggregation and peptide-related impurities
Madison AA, Bailey MT
News Release February 26, 2024 Latest ConsumerLab Survey Shows Growth in Popularity of Magnesium and Several Smaller Supplements White Plains, New York, February 26, 2024 A recent survey of more than 10,000 people who regularly use dietary supplements shows that supplements that experienced the greatest absolute growth in popularity during 2023 were pregnenolone (+7.5 percentage points), magnesium (+4.8 pts), berberine (+4
Day-to-day life produces substances called free radicals that circulate in the body
Using DSIP Peptide Therapy Safely If youre considering DSIP for sleep optimization, heres the framework I recommend based on decades of peptide experimentation and the protocols Ive personally used
Biophys J 92:40024011